- Home
- ONL vs TARA Comparison
ONL vs TARA Comparison
Compare ONL & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONL
- TARA
- Stock Information
- Founded
- ONL 2021
- TARA N/A
- Country
- ONL United States
- TARA United States
- Employees
- ONL N/A
- TARA N/A
- Industry
- ONL Real Estate Investment Trusts
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ONL Real Estate
- TARA Health Care
- Exchange
- ONL Nasdaq
- TARA Nasdaq
- Market Cap
- ONL 119.7M
- TARA 126.5M
- IPO Year
- ONL N/A
- TARA N/A
- Fundamental
- Price
- ONL $2.32
- TARA $3.07
- Analyst Decision
- ONL Hold
- TARA Strong Buy
- Analyst Count
- ONL 1
- TARA 7
- Target Price
- ONL N/A
- TARA $20.67
- AVG Volume (30 Days)
- ONL 1.1M
- TARA 488.2K
- Earning Date
- ONL 08-06-2025
- TARA 08-05-2025
- Dividend Yield
- ONL 3.38%
- TARA N/A
- EPS Growth
- ONL N/A
- TARA N/A
- EPS
- ONL N/A
- TARA N/A
- Revenue
- ONL $154,796,000.00
- TARA N/A
- Revenue This Year
- ONL N/A
- TARA N/A
- Revenue Next Year
- ONL N/A
- TARA N/A
- P/E Ratio
- ONL N/A
- TARA N/A
- Revenue Growth
- ONL N/A
- TARA N/A
- 52 Week Low
- ONL $1.46
- TARA $1.60
- 52 Week High
- ONL $4.39
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- ONL 56.92
- TARA 53.15
- Support Level
- ONL $2.29
- TARA $2.77
- Resistance Level
- ONL $2.41
- TARA $3.23
- Average True Range (ATR)
- ONL 0.13
- TARA 0.18
- MACD
- ONL 0.01
- TARA 0.04
- Stochastic Oscillator
- ONL 63.05
- TARA 88.02
About ONL Orion Office REIT Inc.
Orion Properties Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).